Skip to main content
OpenTrials
Completed

NCT Number: NCT05529160

FERTI-LILY Safety Study

The study is a prospective, 1-arm, open label, nonrandomized, single center study designed to evaluate label comprehension, device usability and safety of the FERTI·LILY Conception Cup. The primary safety endpoint will be an assessment of reported adverse events.

Subjects will be screened -10 (±3) days prior to the baseline visit. At baseline, 15-20 subjects meeting the inclusion/exclusion criteria will be provided with a FERTI·LILY Conception Cup device and instructions for using the device. Subjects will participate in a label comprehension protocol that includes the physician confirmation that they have adequate comprehension to enroll. If not, a screen failure form is completed.

Subjects will agree to try and use the device within 2 weeks of disposition therefore at baseline a two-week visit is scheduled. In the event they do not use the device within the two-week period the follow up visit can be rescheduled based on the visit window of +14 days. If it is not used within 4 weeks, the PI will have the subject return to the site to authorize another two-week period that will be captured as unscheduled follow up visit. The subject should complete the Device Experience Survey after each device use. The Device Experience Survey will be returned at this time, and adverse events will be assessed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Natural Conception Device Usability Label Comprehension Safety Issues

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Boca Raton Obstetrics and Gynecology

Boca Raton, Florida, 33431, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is a female volunteer, age ≥ 18 years.
  • Subject is willing and able to provide written informed consent for study participation.
  • Subject agrees to use the FCC device as directed.
  • Subject agrees to complete all study-related assessments.
  • Subject agrees to try to use the cup within two weeks of disposition.
  • PI confirms that the subject had the adequate label comprehension to enroll in the study.

Exclusion criteria

  • Subject has a medical condition or other factor that, in the opinion of the investigator, would contraindicate participation in the study.
  • Subject has active bacterial vaginosis infection or vaginismus.
  • Subject has an abnormal clinically significant Pap Smear diagnosis.
  • Subject has a history of endometriosis.
  • Subject has any contraindications with the Instructions for Use.
  • Subject has an allergy to silicone.
  • Subject is pregnant or lactating.

Treatment and study plan

FERTI LILY Conception Cup

Device

The FERTI-LILY Conception Cup is indicated for over-the-counter (OTC) home use by couples trying to conceive. The FERTI·LILY device OTC contains a cervical cap attached to a stem. The FERTI-LILY Conception Cup is intended to push semen towards the cervix as an aid in conception. It is designed to be inserted vaginally after intercourse and left in place for 20-60 minutes. The device is recommended to be used during the ovulatory phase of the menstrual cycle. It is not to be left in place for longer than six hours. The device may be re-used up to 18 times or over 6 cycles.

Primary outcomes

  1. Safety of Device

    Time frame: 6 weeks

    Occurrence of device-related adverse events.

Secondary outcomes

  1. Label Comprehension Assessment Protocol

    Time frame: 6 weeks

    PI using questions and answers to assess comprehension and confirms subject can specify location and use of cup in vaginal model.

  2. Device Usability

    Time frame: 6 weeks

    After use reported by subject: ease of use, user compliance, overall satisfaction, comfort, size of device.

Sponsors and collaborators

Lead sponsor

Rosesta Medical BV

Industry

Registry information

Official study title

A Prospective, 1-Arm, Open Label, Non-Randomized Study of the FERTI-LILY Conception Cup Device to Assess Label Comprehension, Device Usability and Safety in Women

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Sep 6, 2022
Registry last updated
Apr 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.